NCT01301716 2016-11-02A Study of the Safety and Pharmacology of GDC-0980 in Combination With Either Paclitaxel and Carboplatin (With or Without Bevacizumab) or Pemetrexed and Cisplatin in Patients With Solid TumorsGenentech, Inc.Phase 1 Completed75 enrolled